Hims & Hers Health Inc - Class A
NYSE: HIMS
$39.78
-$11.53 (-22.5%)
Closing Price on February 25, 2025
HIMS Stock Chart and Intraday Price
HIMS Stock Data
| Asset Type | Stock |
| Exchange | NYSE |
| Currency | USD |
| Country | USA |
| Sector | LIFE SCIENCES |
| Industry | SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE |
| Address | 333 S. GRAND AVE., 28TH FLOOR, LOS ANGELES, CA, US |
| Fiscal Year End | December |
| Latest Quarter | 12/31/2023 |
| Market Cap | 2,810.96M USD |
| Shares Outstanding | 205,873,000 |
HIMS Articles
Shares of Hims & Hers Health (NASDAQ:HIMS) continued to meltdown Tuesday in noontime trading after the direct-to-consumer healthcare platform said it couldn’t guarantee it would be able to...
Published:
The market’s attempts at gains have been denied in the face of weaker consumer confidence in February than had been expected. The Dow Jones Industrial Average came out of the gate with gains,...
Published:
Last Updated:
The Food & Drug Administration announced last week that the Ozempic and Wegovy shortage for Novo Nordisk‘s (NYSE:NVO) was over. It said the Danish pharmaceutical had sufficient supply of its...
Published:
Shares of Hims & Hers Health (NYSE:HIMS) are down about 21%, or $14. All on news the Ozempic shortage is over. About This Article Just this morning, the US FDA said Novo Nordisk’s popular...
Published:
The markets are trading lower with the S&P 500 retreating from its recently minted record high levels while the negative sentiment has also spilled over to the Dow Jones Industrial Average and...
Published:
Stock markets got a bit of a shock on Friday after a University of Michigan survey showed consumers are anticipating inflation to rise in 2025, potentially depressing consumer spending and dissuading...
Published:
Next to artificial intelligence, weight-loss drugs have been one of the biggest themes investors latched onto in 2024. Eli Lilly (NYSE:LLY) has become the industry leader in a class of drugs called...
Published:
Stocks are running in premarket trading on Monday. Here’s a look at major indexes as of 8:50 a.m. ET: Nasdaq Futures: Up 205.25 (+.95%) S&P 500 Futures: Up 45.25 (+.76%) Dow Jones Futures: Up...
Published:
Capitalizing on the popularity of weight-loss drugs like Wegovy and Zepbound, Hims & Hers Health (NYSE:HIMS) has exploited a loophole in Food & Drug Administration regulations to bring to...
Published:
Summer has officially begun, but some stocks are receiving a chilly reception today. Among them, Hims & Hers Health (NYSE: HIMS), a telehealth and wellness platform, is down over 11% on the day...
Published:
Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.
You can follow him investing $500,000 of his own money on our top AI stocks for free.